MedTrace Logo

Basic Life Support by Children

NCT04440111 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2020-06-19

No results posted yet for this study

Summary

A controlled clinical trial will be performed.

School children from the age of 10 to 11 will be selected to learn basic life support (BLS) in a primary school of Zaragoza.

One of the groups will learn BLS in two consecutive years and the other group will learn BLS only the first year.

The investigators think that the knowledge will be better in the group that receives two interventions.

Conditions

  • Cardiopulmonary Arrest With Successful Resuscitation
  • Child, Only

Interventions

OTHER

One year training

At first, children will make a test to evaluate their pre- intervention basic support life knowledge. Secondly, they will receive a theoretical class about BLS, based on European Resuscitation Council Guide 2015. After that, they will make a practical workshop on BLS. Finally they will repeat the initial test. The second year, this group will only make the test, they won't receive any theory or practice.

OTHER

Two years training

At first, children will make a test to evaluate their pre- intervention basic support life knowledge. Secondly, they will receive a theoretical class about BLS, based on European Resuscitation Council Guide 2015. After that they will make a practical workshop on BLS. Finally they will repeat the initial test. The second year, this group will repeat the same process.

Sponsors & Collaborators

  • Hospital Miguel Servet

    collaborator OTHER

  • Cristina Genzor

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-11
Primary Completion
2020-02-27
Completion
2021-04-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04440111 on ClinicalTrials.gov